Pre-made Imciromab benchmark antibody (Radiolabelled antibody, anti-myosin therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-863

Pre-made Imciromab benchmark antibody (Radiolabelled antibody, anti-myosin therapeutic antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Indium (111In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111.[1] It was used for cardiac imaging, but withdrawn in 1993.[2]

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-863-1mg 1mg 3090
GMP-Bios-INN-863-10mg 10mg Inquiry
GMP-Bios-INN-863-100mg 100mg Inquiry
GMP-Bios-INN-863-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Imciromab Biosimilar, Radiolabelled Antibody: Anti-Myosin therapeutic antibody
INN Name Imciromab
Targetmyosin
FormatRadiolabelled antibody
DerivationMus musculus
Species Reactivityhuman
CH1 IsotypeFab - G2a - kappa
VD LCFab - G2a - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesCentocor Inc. (Horsham PA USA) / Eli Lilly (Indianapolis IN USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0